Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
ClinicalTrials.gov study NCT03415854. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT00378313. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02399137. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy
ClinicalTrials.gov study NCT02252887. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Real World Efficacy, Safety of Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Metastatic Pancreatic Cancer After Previous Gemcitabine-based Therapy
ClinicalTrials.gov study NCT06006728. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents
ClinicalTrials.gov study NCT00191438. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00304135. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
ClinicalTrials.gov study NCT00075686. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02954406. IPD Sharing: YES. Countries: 2. Publications: 0.
Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma
ClinicalTrials.gov study NCT00169195. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00030732. IPD Sharing: Not stated. Countries: 4. Publications: 5.
Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
ClinicalTrials.gov study NCT00006482. IPD Sharing: Not stated. Countries: 2. Publications: 1.
S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
ClinicalTrials.gov study NCT00012363. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)
ClinicalTrials.gov study NCT00655785. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01303029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04692051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
ClinicalTrials.gov study NCT01352962. IPD Sharing: YES. Countries: 1. Publications: 3.
Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01956812. IPD Sharing: Not stated. Countries: 8. Publications: 19.
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma
ClinicalTrials.gov study NCT01684449. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer
ClinicalTrials.gov study NCT04133155. IPD Sharing: NO. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.